Synthetic Cannabinoids Market
Synthetic Cannabinoids Market Analysis by Dronabinol and Nabilone for Pain Management, Nausea/Vomiting, and Neurological Disorder Management from 2023 to 2033
Analysis of Synthetic Cannabinoids Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Synthetic Cannabinoids Market Overview (2023 to 2033)
The global synthetic cannabinoids market size is accounted for a US$ 2.65 billion value in 2023 and is forecasted to expand at an astronomical 20.6% CAGR from 2023 to 2033. By the end of 2033, worldwide demand for synthetic cannabinoids is projected to bring in a revenue of US$ 17.3 billion.
Synthetic cannabinoids are lab-made drugs originally designed to produce similar effects to cannabis but which are often far stronger and carry a greater health risk. The global synthetic cannabinoids market growth is likely to pin its hope on the regulatory framework about the intake of synthetic cannabinoid products. The rising popularity of e-cigarettes linked with the growing affinity toward the usage of synthetic cannabinoids as a substitute for non-synthetic cannabis in several regions of the world is likely to offer a significant boost to the consumption of synthetic cannabinoids.
Synthetic cannabinoids are sold as a legal and safe alternative to marijuana in several parts of the world owing to which, the sales of synthetic cannabinoids have observed growth, particularly among the millennial population.
- Synthetic cannabinoids for medical purposes have been commercialized since 2017 and are showing rapid adoption for different medical ailments. Synthetic cannabinoids have emerged as novel therapeutic drugs for epilepsy, spasticity, inflammation, etc.
Use of synthetic cannabinoids to treat nausea and anxiety caused by cancer chemotherapy is projected to open up new avenues of opportunities for synthetic cannabinoid manufacturers in the future. The growing use of synthetic cannabinoid therapies for the treatment of diseases such as arthritis, and acute and chronic pain is also predicted to uplift the demand for synthetic cannabinoids going forward.
Reliance on synthetic cannabinoids as recreational drugs is also projected to increase over the coming years and this could hurt overall market development in the long run. The psychoactive effects of synthetic cannabinoids are largely unknown and abuse of these substances could result in multiple mental and physical health complications. Hence, illegal and recreational use of synthetic cannabinoids is forecasted to be the key restraint for global market growth through 2033 and beyond.
| Report Attributes | Details |
|---|---|
| Synthetic Cannabinoids Market Size (2023E) | US$ 2.65 Billion |
| Projected Market Value (2033F) | US$ 17.3 Billion |
| Global Market Growth Rate (2023 to 2033) | 20.6% CAGR |
| Dronabinol Segment Share (2023) | 90% |
| Europe Market Share (2023) | ~30% |
| Key Companies Profiled | Noramco Inc.; Kannalife; FSD Pharma; CannBioRx Life Sciences; TheraPix Biosciences; Tetra Bio-Pharma; Zynerba Pharmaceuticals; Hyasynth Biologicals Inc.; GW Pharmaceuticals |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How are Manufacturers Streamlining Synthetic Cannabinoid Production?
“Use of Novel Techniques Such as Biosynthesis”
Earlier, manufacturers of synthetic cannabinoids were using naïve techniques of production with the help of specialized strains of yeast. Companies such as Librede Inc. and Hyasynth Biologicals Inc. are actively producing synthetic cannabinoids by using bioengineered yeast strains.
Other manufacturers such as Renew Biopharma have been innovating the production process of synthetic cannabinoids with the help of bioengineered microorganisms. The use of bioengineered microorganisms for the synthesis of synthetic cannabinoids instead of conventional processes helps enhance the purity of the compound.
Synthetic cannabinoid providers are coming up with new techniques of production to reduce costs and improve profits.
- In January 2022, Dyadic International Inc., a renowned biotechnology firm, announced that its C1-cell protein cells could be engineered to manufacture cannabis compounds using synthetic biology. C1-cells had the potential to make manufacturing of synthetic cannabinoids cheaper and more economically viable than traditional methods.
Why are Synthetic Cannabinoid Companies Focusing on North America?
“Extensive Availability of Cannabinoids and Growing Adoption of CBDs”
The synthetic cannabinoids market in North America is projected to expand at a significant pace throughout the forecast period. This can be attributed to the extensive availability of products and the existence of prominent companies constantly encouraging their brand among healthcare professionals in the region.
- Recent approvals of cannabidiol drugs by the FDA in the U.S. for the treatment of two severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome are anticipated to drive the market in the country and region.
As the government-approved production and supply of cannabis-derived pharmaceutical products increases in the United States, there are signs that synthetic cannabinoids will benefit the pharma industry over cannabinoids obtained from marijuana plants, providing an opportunity for synthetic cannabinoid manufacturers.
- Shipments of synthetic cannabinoids in North America accounted for around 50% of the global market share in 2022.
Increasing legalization of cannabis and cannabinoids in different states of the country is also projected to offer new opportunities for business growth in the future. Canada is also forecasted to emerge as a highly rewarding space for synthetic cannabinoid companies by the end of the study period.
Learn more about all major and minor regions with details of aspects such as local supply, pricing trends, product standards, safety regulations, and new developments in this synthetic cannabinoids market research analysis by skilled analysts at Fact.MR, a market research and competitive intelligence provider.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
Apart from the North American region, synthetic cannabinoid brands can invest in countries such as China, Japan, Germany, and the United Kingdom to expand their business scope.
What Stands in the Way of Success for Synthetic Cannabinoid Providers in APAC?
“Stringent Regulatory Mandates and Cultural Attitude towards Cannabis”
Safety concerns and the potential risk of abuse associated with synthetic cannabinoids have pushed governments in the Asia Pacific region to implement strict regulatory mandates to govern the demand and supply of synthetic cannabinoids. Synthetic cannabinoid suppliers looking to improve their revenue from Asian countries such as India, China, and Japan need to comply with the aforementioned stringent norms to do business in these countries.
- In May 2021, the Chinese authorities announced that all synthetic cannabinoids were added to the list of banned drugs in the country. The National Narcotics Control Commission of China was behind this move and stated that this was done to curb the trafficking and abuse of these drugs.
India, China, and Japan are countries where the approach towards medicine has historically leaned toward a more natural approach rather than synthetic and modern. The cultural attitude towards synthetic products is not very bright in the Asian region and this could also pose a challenge for synthetic cannabinoid manufacturers in the future.
How Will Synthetic Cannabinoid Demand Fare in Europe?
“Growing Use of Synthetic Cannabinoids for Scientific Studies”
Pharmaceutical and biotechnology companies in the European region are continually investing in R&D activities to create novel treatments and drugs for different diseases. The presence of a supportive regulatory framework that allows the use of synthetic cannabinoids in scientific studies and research programs in European countries is projected to create new growth opportunities for synthetic cannabinoid suppliers over the next ten years.
Category-wise Insights
Synthetic cannabinoid manufacturers should invest in the development of novel drugs using dronabinol to maximize their revenue generation potential over the coming years.
Which Synthetic Cannabinoid Type is High in Demand?
“Dronabinol Accounts Prominent Share in Global Market”
Dronabinol as a type of synthetic cannabinoid has maintained its lead in the market and is expected to experience a higher growth rate vis-a-vis Nabilone. Dronabinol for medical use is being manufactured by almost all prominent market players. Moreover, Dronabinol is an emerging suitable therapeutic compound that binds to cannabinoid (CBR) receptors giving desired results during disease treatment.
- Dronabinol sales account for around 90% of global market revenue at present.
Dronabinol has superior investment backing which is boosting its uptake in the market. A vast majority of the companies in the synthetic cannabinoids market have been focusing on products that are in their clinical trial phase.
- For instance, TheraPix Biosciences, Tetra Bio-Pharma, and Zynerba Pharmaceuticals are some of the companies that are conducting clinical trials for their compounds.
- Other companies like GW Pharmaceuticals, Kannalife, and FSD Pharma are developing synthetic cannabinoids. Such novel initiatives will enable manufacturers to expand their profit pools in the synthetic cannabinoids market.
Nabilone showcases a marginal contribution to the global synthetic cannabinoids market at present and is projected to record a robust hike in demand in the future due to its increased pharmaceutical usage in the United States, Canada, and Europe.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Synthetic cannabinoid distributors are partnering with research associations and organizations to carry out potential research on synthetic cannabinoids. Pharma giants are also investing in startup companies to push research on synesthetic cannabinoids and expand the production capacities of synthetic cannabinoids.
- In September 2021, Noramco announced that its cannabinoids business division will become a separate company named Purisys LLC, and is expanding its production capacity of Dronabinol and cannabidiol (CBD) in its production facility based in Athens, United States.
- In September 2021, Hyasynth, a sustainable biotechnology company, was awarded a $2.5M milestone payment from Organigram Holdings Inc., for its commercialization achievements in being first-to-market with cannabidiol (CBD) produced and extracted from yeast.
Key Segments of Synthetic Cannabinoids Market Research
-
By Type :
- Dronabinol
- Nabilone
-
By Indication :
- Pain Management
- Nausea/Vomiting
- Neurological Disorder Management
- Others
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Data - Introduction
- 3. Key Market Trends
- 4. Market Background and Associated Industry Indicators
- 5. Global Market Demand Analysis 2022 and Forecast, 2023 to 2033
- 6. Global Market - Pricing Analysis
- 7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2022 and Forecast, 2023 to 2033
- 8. Global Market Demand (US$ Mn) Analysis 2022 and Forecast, 2023 to 2033
- 9. Global Market Demand Analysis 2022 and Forecast, 2023 to 2033
- 10. Global Market Analysis 2022 and Forecast 2023 to 2033, By Type
- 10.1. Dronabinol
- 10.2. Nabilone
- 11. Global Market Analysis 2022 and Forecast 2023 to 2033, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. Asia Pacific
- 11.5. Middle East and Africa (MEA)
- 12. North America Market Analysis 2022 and Forecast 2023 to 2033
- 13. Latin America Market Analysis 2022 and Forecast 2023 to 2033
- 14. Europe Market Analysis 2022 and Forecast 2023 to 2033
- 15. Asia Pacific Market Analysis 2022 and Forecast 2023 to 2033
- 16. Middle East and Africa Market Analysis 2022 and Forecast 2023 to 2033
- 17. Market Structure Analysis
- 18. Company Profiles
- 18.1. Hyasynth Biologicals, Inc.
- 18.2. Noramco, Inc.
- 18.3. CB Therapeutics, Inc.
- 18.4. Insys Therapeutics, Inc.
- 18.5. CV Sciences, Inc.
- 18.6. Ginkgo Bioworks, Inc.
- 18.7. CannBioRx Life Sciences
- 18.8. LIBREDE, INC.
- 19. Research Methodology
- 20. Assumptions and Acronyms
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Kgs) By Region, 2018 to 2033
Table 02: Global Market Value (US$ Mn) By Region, 2018 to 2033
Table 03: Global Market Volume (Kgs) By Type, 2018 to 2033
Table 04: Global Market Value (US$ Mn) By Type, 2018 to 2033
Table 05: North America Market Volume (Kgs) By Country, 2018 to 2033
Table 06: North America Market Value (US$ Mn) By Country, 2018 to 2033
Table 07: North America Market Volume (Kgs) By Type, 2018 to 2033
Table 08: North America Market Value (US$ Mn) By Type, 2018 to 2033
Table 09: Latin America Market Volume (Kgs) By Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Mn) By Country, 2018 to 2033
Table 11: Latin America Market Volume (Kgs) By Type, 2018 to 2033
Table 12: Latin America Market Value (US$ Mn) By Type, 2018 to 2033
Table 13: Europe Market Volume (Kgs) By Country, 2018 to 2033
Table 14: Europe Market Value (US$ Mn) By Country, 2018 to 2033
Table 15: Europe Market Volume (Kgs) By Type, 2018 to 2033
Table 16: Europe Market Value (US$ Mn) By Type, 2018 to 2033
Table 17: Asia-Pacific Market Volume (Kgs) By Country, 2018 to 2033
Table 18: Asia-Pacific Market Value (US$ Mn) By Country, 2018 to 2033
Table 19: Asia-Pacific Market Volume (Kgs) By Type, 2018 to 2033
Table 20: Asia-Pacific Market Value (US$ Mn) By Type, 2018 to 2033
Table 21: MEA Market Volume (Kgs) By Country, 2018 to 2033
Table 22: MEA Market Value (US$ Mn) By Country, 2018 to 2033
Table 23: MEA Market Volume (Kgs) By Type, 2018 to 2033
Table 24: MEA Market Value (US$ Mn) By Type, 2018 to 2033
Table 25: Global Market Volume (Kgs) By Region, 2018 to 2033
Table 26: Global Market Value (US$ Mn) By Region, 2018 to 2033
Table 27: Global Market Volume (Kgs) By Type, 2018 to 2033
Table 28: Global Market Value (US$ Mn) By Type, 2018 to 2033
Table 29: North America Market Volume (Kgs) By Country, 2018 to 2033
Table 30: North America Market Value (US$ Mn) By Country, 2018 to 2033
Table 31: North America Market Volume (Kgs) By Type, 2018 to 2033
Table 32: North America Market Value (US$ Mn) By Type, 2018 to 2033
Table 33: US Market Volume (Kgs) By Type, 2018 to 2033
Table 34: US Market Value (US$ Mn) By Type, 2018 to 2033
Table 35: Canada Market Volume (Kgs) By Type, 2018 to 2033
Table 36: Canada Market Value (US$ Mn) By Type, 2018 to 2033
Table 37: Latin America Market Volume (Kgs) By Country, 2018 to 2033
Table 38: Latin America Market Value (US$ Mn) By Country, 2018 to 2033
Table 39: Latin America Market Volume (Kgs) By Type, 2018 to 2033
Table 40: Latin America Market Value (US$ Mn) By Type, 2018 to 2033
Table 41: Uruguay Market Volume (Kgs) By Type, 2018 to 2033
Table 42: Uruguay Market Value (US$ Mn) By Type, 2018 to 2033
Table 43: Argentina Market Volume (Kgs) By Type, 2018 to 2033
Table 44: Argentina Market Value (US$ Mn) By Type, 2018 to 2033
Table 45: Brazil Market Volume (Kgs) By Type, 2018 to 2033
Table 46: Brazil Market Value (US$ Mn) By Type, 2018 to 2033
Table 47: Mexico Market Volume (Kgs) By Type, 2018 to 2033
Table 48: Mexico Market Value (US$ Mn) By Type, 2018 to 2033
Table 49: Rest of Latin America Market Volume (Kgs) By Type, 2018 to 2033
Table 50: Rest of Latin America Market Value (US$ Mn) By Type, 2018 to 2033
Table 51: Europe Market Volume (Kgs) By Country, 2018 to 2033
Table 52: Europe Market Value (US$ Mn) By Country, 2018 to 2033
Table 53: Europe Market Volume (Kgs) By Type, 2018 to 2033
Table 54: Europe Market Value (US$ Mn) By Type, 2018 to 2033
Table 55: Germany Market Volume (Kgs) By Type, 2018 to 2033
Table 56: Germany Market Value (US$ Mn) By Type, 2018 to 2033
Table 57: UK Market Volume (Kgs) By Type, 2018 to 2033
Table 58: UK Market Value (US$ Mn) By Type, 2018 to 2033
Table 59: France Market Volume (Kgs) By Type, 2018 to 2033
Table 60: France Market Value (US$ Mn) By Type, 2018 to 2033
Table 61: Spain Market Volume (Kgs) By Type, 2018 to 2033
Table 62: Spain Market Value (US$ Mn) By Type, 2018 to 2033
Table 63: Italy Market Volume (Kgs) By Type, 2018 to 2033
Table 64: Italy Market Value (US$ Mn) By Type, 2018 to 2033
Table 65: BENELUX Market Volume (Kgs) By Type, 2018 to 2033
Table 66: BENELUX Market Value (US$ Mn) By Type, 2018 to 2033
Table 67: Rest of Europe Market Volume (Kgs) By Type, 2018 to 2033
Table 68: Rest of Europe Market Value (US$ Mn) By Type, 2018 to 2033
Table 69: Asia-Pacific Market Volume (Kgs) By Country, 2018 to 2033
Table 70: Asia-Pacific Market Value (US$ Mn) By Country, 2018 to 2033
Table 71: Asia-Pacific Market Volume (Kgs) By Type, 2018 to 2033
Table 72: Asia-Pacific Market Value (US$ Mn) By Type, 2018 to 2033
Table 73: Thailand Market Volume (Kgs) By Type, 2018 to 2033
Table 74: Thailand Market Value (US$ Mn) By Type, 2018 to 2033
Table 75: Australia Market Volume (Kgs) By Type, 2018 to 2033
Table 76: Australia Market Value (US$ Mn) By Type, 2018 to 2033
Table 77: New Zealand Market Volume (Kgs) By Type, 2018 to 2033
Table 78: New Zealand Market Value (US$ Mn) By Type, 2018 to 2033
Table 79: South Korea Market Volume (Kgs) By Type, 2018 to 2033
Table 80: South Korea Market Value (US$ Mn) By Type, 2018 to 2033
Table 81: MEA Market Volume (Kgs) By Country, 2018 to 2033
Table 82: MEA Market Value (US$ Mn) By Country, 2018 to 2033
Table 83: MEA Market Volume (Kgs) By Type, 2018 to 2033
Table 84: MEA Market Value (US$ Mn) By Type, 2018 to 2033
Table 85: South Africa Market Volume (Kgs) By Type, 2018 to 2033
Table 86: South Africa Market Value (US$ Mn) By Type, 2018 to 2033
Table 87: Israel Market Volume (Kgs) By Type, 2018 to 2033
Table 88: Israel Market Value (US$ Mn) By Type, 2018 to 2033
Table 89: Rest of MEA Market Volume (Kgs) By Type, 2018 to 2033
Table 90: Rest of MEA Market Value (US$ Mn) By Type, 2018 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Share by Type - 2023 & 2033
Figure 02: Global Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 03: Global Market Attractiveness Analysis by Type, 2023 to 2033
Figure 04: Global Market by Dronabinol Value (US$ Mn), Volume (Kgs) and Forecast, 2023 to 2033
Figure 05: Global Market by Dronabinol Incremental $ Opportunity, 2023 to 2033
Figure 06: Global Market by Nabilone Value (US$ Mn), Volume (Kgs) and Forecast, 2023 to 2033
Figure 07: Global Market by Nabilone Incremental $ Opportunity, 2023 to 2033
Figure 08: Global Market Share Analysis by Region - 2023 & 2033
Figure 09: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 10: Global Market Attractiveness Index by Region, 2023 to 2033
Figure 11: North America Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 12: North America Market Share Analysis by Type, 2023 & 2033
Figure 13: North America Market Y-o-Y Growth Projection by Type, 2023 to 2033
Figure 14: North America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 15: North America Market Share Analysis by Country, 2023 & 2033
Figure 16: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 17: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 18: US Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 19: US Market Share Analysis by Type, 2023 & 2033
Figure 20: Canada Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 21: Canada Market Share Analysis by Type, 2023 & 2033
Figure 22: Latin America Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 23: Latin America Market Share Analysis by Type, 2023 & 2033
Figure 24: Latin America Market Y-o-Y Growth Projection by Type, 2023 to 2033
Figure 25: Latin America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 26: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 27: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 28: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 29: Uruguay Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 30: Uruguay Market Share Analysis by Type, 2023 & 2033
Figure 31: Argentina Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 32: Argentina Market Share Analysis by Type, 2023 & 2033
Figure 33: Brazil Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 34: Brazil Market Share Analysis by Type, 2023 & 2033
Figure 35: Mexico Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 36: Mexico Market Share Analysis by Type, 2023 & 2033
Figure 37: Rest of Latin America Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 38: Rest of Latin America Market Share Analysis by Type, 2023 & 2033
Figure 39: Europe Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 40: Europe Market Share Analysis by Type, 2023 & 2033
Figure 41: Europe Market Y-o-Y Growth Projection by Type, 2023 to 2033
Figure 42: Europe Market Attractiveness Analysis by Type, 2023 to 2033
Figure 43: Europe Market Share Analysis by Country, 2023 & 2033
Figure 44: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 45: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 46: Germany Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 47: Germany Market Share Analysis by Type, 2023 & 2033
Figure 48: UK Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 49: UK Market Share Analysis by Type, 2023 & 2033
Figure 50: France Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 51: France Market Share Analysis by Type, 2023 & 2033
Figure 52: Spain Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 53: Spain Market Share Analysis by Type, 2023 & 2033
Figure 54: Italy Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 55: Italy Market Share Analysis by Type, 2023 & 2033
Figure 56: Benelux Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 57: Benelux Market Share Analysis by Type, 2023 & 2033
Figure 58: Rest of Europe Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 59: Rest of Europe Market Share Analysis by Type, 2023 & 2033
Figure 60: Asia-Pacific Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 61: Asia-Pacific Market Share Analysis by Type, 2023 & 2033
Figure 62: Asia-Pacific Market Y-o-Y Growth Projection by Type, 2023 to 2033
Figure 63: Asia-Pacific Market Attractiveness Analysis by Type, 2023 to 2033
Figure 64: Asia-Pacific Market Share Analysis by Country, 2023 & 2033
Figure 65: Asia-Pacific Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 66: Asia-Pacific Market Attractiveness Analysis by Country, 2023 to 2033
Figure 67: Thailand Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 68: Thailand Market Share Analysis by Type, 2023 & 2033
Figure 69: Australia Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 70: Australia Market Share Analysis by Type, 2023 & 2033
Figure 71: New Zealand Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 72: New Zealand Market Share Analysis by Type, 2023 & 2033
Figure 73: South Korea Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 74: South Korea Market Share Analysis by Type, 2023 & 2033
Figure 75: MEA Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 76: MEA Market Share Analysis by Type, 2023 & 2033
Figure 77: MEA Market Y-o-Y Growth Projection by Type, 2023 to 2033
Figure 78: MEA Market Attractiveness Analysis by Type, 2023 to 2033
Figure 79: MEA Market Share Analysis by Country, 2023 & 2033
Figure 80: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 81: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 82: South Africa Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 83: South Africa Market Share Analysis by Type, 2023 & 2033
Figure 84: Israel Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 85: Israel Market Share Analysis by Type, 2023 & 2033
Figure 86: Rest of MEA Market Value (US$ Mn), Volume (Kgs) Forecast and Analysis, 2023 to 2033
Figure 87: Rest of MEA Market Share Analysis by Type, 2023 & 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the synthetic cannabinoids market in 2023?
The global synthetic cannabinoids market stands at a value of US$ 2.65 billion in 2023.
What is the projected market value for synthetic cannabinoids by 2033?
Synthetic cannabinoid sales are forecasted to reach US$ 17.3 billion by 2033-end.
At what CAGR will the global market expand in the future?
Synthetic cannabinoid sales are projected to rise at a phenomenal 20.6% CAGR over the next ten years.
What is the strongest synthetic cannabinoid?
JWH-018 is widely accepted as a strong synthetic cannabinoid.
Which country banned synthetic cannabinoids?
China banned synthetic cannabinoids in May 2021.
Who are the leading synthetic cannabinoid suppliers?
Noramco Inc., Kannalife, FSD Pharma, CannBioRx Life Sciences, and TheraPix Biosciences are leading market players.
Synthetic Cannabinoids Market